Viekira Pak Interactions
There are 719 drugs known to interact with Viekira Pak (dasabuvir/ombitasvir/paritaprevir/ritonavir), along with 9 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 276 are major, 402 are moderate, and 41 are minor.
- View all 719 medications that may interact with Viekira Pak
- View Viekira Pak alcohol/food interactions (3)
- View Viekira Pak disease interactions (9)
Most frequently checked interactions
View interaction reports for Viekira Pak (dasabuvir / ombitasvir / paritaprevir / ritonavir) and the medicines listed below.
- AccessPak for HIV PEP Expanded with Kaletra (emtricitabine / lopinavir / ritonavir / tenofovir disoproxil)
- acetylcysteine
- Actifed Cold & Sinus (acetaminophen / chlorpheniramine / pseudoephedrine)
- Adderall XR (amphetamine / dextroamphetamine)
- Afinitor Disperz (everolimus)
- Alcohol (contained in alcoholic beverages) (ethanol)
- alendronate
- alprazolam
- Ambien (zolpidem)
- Ambien CR (zolpidem)
- amitriptyline
- BeneFix (coagulation factor ix)
- bupropion
- Daklinza (daclatasvir)
- diltiazem
- Enbrel (etanercept)
- hydralazine
- Klonopin (clonazepam)
- losartan
- Metoprolol Succinate ER (metoprolol)
- Moderiba (ribavirin)
- omeprazole
- OxyContin (oxycodone)
- ribavirin
- Soliris (eculizumab)
- Suboxone (buprenorphine / naloxone)
- tramadol
- Valium (diazepam)
- Vyvanse (lisdexamfetamine)
- Xanax (alprazolam)
Viekira Pak alcohol/food interactions
There are 3 alcohol/food interactions with Viekira Pak (dasabuvir / ombitasvir / paritaprevir / ritonavir).
Viekira Pak disease interactions
There are 9 disease interactions with Viekira Pak (dasabuvir / ombitasvir / paritaprevir / ritonavir) which include:
- cirrhosis
- liver impairment
- immunosuppression
- hepatic dysfunction
- hemophilia
- hyperglycemia
- hyperlipidemia
- heart block
- hepatotoxicity
Report options
More about Viekira Pak (dasabuvir / ombitasvir / paritaprevir / ritonavir)
- Viekira Pak consumer information
- Compare alternatives
- Reviews (13)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antiviral combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Epclusa
Epclusa treats chronic hepatitis C in adults and children 3+. This once-daily antiviral combines ...
Harvoni
Harvoni is used to treat hepatitis C virus (HCV) infections in adults and children aged 3 years and ...
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Mavyret
Mavyret (glecaprevir/pibrentasvir) is an oral combination medicine containing fixed doses of two ...
Sovaldi
Sovaldi (sofosbuvir) is used to treat chronic hepatitis C virus (HCV) infection. Includes Sovaldi ...
Pegasys
Pegasys is used to treat chronic hepatitis B or C. Learn about side effects, interactions and ...
Vosevi
Vosevi (sofosbuvir,velpatasvir and voxilaprevir) is used to treat chronic hepatitis C. Includes ...
Glecaprevir/pibrentasvir
Glecaprevir/pibrentasvir (Mavyret) is an oral combination medicine containing fixed doses of 2 ...
Interferon alfa-2b
Interferon alfa-2b systemic is used for angioblastoma, condylomata acuminata, conjunctival ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
